Paris-Saclay Cancer Cluster: Accelerating French Innovation in Cancer Treatment
France is mounting a significant offensive against cancer with a latest initiative designed to drastically shorten the timeline between scientific discovery and patient access to innovative treatments. The Paris-Saclay Cancer Cluster (PSCC), launched in 2022, is poised to receive up to €100 million over the next decade as part of the France 2030 program, coupled … Read more